Terns Pharmaceuticals
Terns Pharmaceuticals Logo
About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing molecularly-targeted, oral small-molecule therapies for serious diseases, including oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its pipeline includes TERN-701 for chronic myeloid leukemia, TERN-501 for MASH, and TERN-601 for obesity. The company serves customers worldwide.
Address
1065 East Hillsdale Boulevard, Suite 100
Foster City, 94404
United States
Year founded
2020
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
